StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research report report published on Wednesday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 1.0 % BTX stock opened at $2.88 on Wednesday. Brooklyn ImmunoTherapeutics has a 52 week low of $0.17 and a 52 week […]
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research report released on Wednesday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE:BTX opened at $2.88 on Wednesday. The company’s fifty day moving average price is $3.42 and its 200-day moving average price is […]
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report published on Tuesday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 1.2 % Brooklyn ImmunoTherapeutics stock opened at $3.26 on Tuesday. Brooklyn ImmunoTherapeutics has a twelve month low of $0.17 and a twelve month high […]
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research note released on Monday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 0.6 % Shares of BTX opened at $3.27 on Monday. Brooklyn ImmunoTherapeutics has a 12-month low of $0.17 and a 12-month high […]